33 related articles for article (PubMed ID: 7674811)
1. Protective effects of Hawthorn (Crataegus oxyacantha) extract against digoxin-induced arrhythmias in rats.
Alp H; Soner BC; Baysal T; Şahin AS
Anatol J Cardiol; 2015; 15(12):970-5. PubMed ID: 25880053
[TBL] [Abstract][Full Text] [Related]
2. The persistent sodium current blocker riluzole is antiarrhythmic and anti-ischaemic in a pig model of acute myocardial infarction.
Weiss SM; Saint DA
PLoS One; 2010 Nov; 5(11):e14103. PubMed ID: 21124787
[TBL] [Abstract][Full Text] [Related]
3. Actions of flecainide on susceptibility to phase-2 ventricular arrhythmias during infarct evolution in rat isolated perfused hearts.
Clements-Jewery H; Kanaganayagam GS; Kabra R; Curtis MJ
Br J Pharmacol; 2006 Mar; 147(5):468-75. PubMed ID: 16415912
[TBL] [Abstract][Full Text] [Related]
4. Phase 2 ventricular arrhythmias in acute myocardial infarction: a neglected target for therapeutic antiarrhythmic drug development and for safety pharmacology evaluation.
Clements-Jewery H; Hearse DJ; Curtis MJ
Br J Pharmacol; 2005 Jul; 145(5):551-64. PubMed ID: 15852034
[TBL] [Abstract][Full Text] [Related]
5. The antiarrhythmic efficacy of intravenous anipamil against occlusion and reperfusion arrhythmias.
MacLeod BA; Moult M; Saint KM; Walker MJ
Br J Pharmacol; 1989 Dec; 98(4):1165-72. PubMed ID: 2611487
[TBL] [Abstract][Full Text] [Related]
6. Actions of the verapamil analogues, anipamil and ronipamil, against ischaemia-induced arrhythmias in conscious rats.
Curtis MJ; Walker MJ; Yuswack T
Br J Pharmacol; 1986 Jun; 88(2):355-61. PubMed ID: 3755364
[TBL] [Abstract][Full Text] [Related]
7. Effects of anipamil on electrocardiogram, plasma creatine kinase, and reperfusion arrhythmias after coronary occlusion in closed-chest rats.
Kirchengast M; Raschack M
J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S73-5. PubMed ID: 2475696
[TBL] [Abstract][Full Text] [Related]
8. Antiarrhythmic actions of a long acting verapamil analogue, anipamil, in pigs.
Ries C; Harvie CJ; Walker MJ; Pugsley MK
Proc West Pharmacol Soc; 1993; 36():95-8. PubMed ID: 8378404
[No Abstract] [Full Text] [Related]
9. Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872.
Bril A; Gout B; Bonhomme M; Landais L; Faivre JF; Linee P; Poyser RH; Ruffolo RR
J Pharmacol Exp Ther; 1996 Feb; 276(2):637-46. PubMed ID: 8632331
[TBL] [Abstract][Full Text] [Related]
10. Effects of anipamil, a long acting analog of verapamil, in pigs subjected to myocardial ischemia.
Pugsley MK; Ries CR; Guppy LJ; Harvie CJ; Walker MJ
Life Sci; 1995; 57(12):1219-31. PubMed ID: 7674811
[TBL] [Abstract][Full Text] [Related]
11. Rationale of therapy in the patient with acute myocardial infarction and life-threatening arrhythmias: a focus on bretylium.
Lucchesi BR
Am J Cardiol; 1984 Jul; 54(2):14A-19A. PubMed ID: 6380259
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensive, anticalcinotic, and antiarteriosclerotic properties of anipamil, a long-acting new derivative of verapamil.
Frey M; Zorn J; Fleckenstein-Grün G; Fleckenstein A
J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S23-8. PubMed ID: 2475679
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
